Tops C - Search Results

1

Value-based healthcare in Lynch syndrome.

Hennink SD, Hofland N, Gopie JP, van der Kaa C, de Koning K, Nielsen M, Tops C, Morreau H, de Vos tot Nederveen Cappel WH, Langers AM, Hardwick JC, Gaarenstroom KN, Tollenaar RA, Veenendaal RA, Tibben A, Wijnen J, van Heck M, van Asperen C, Roukema AJ, Hommes DW, Hes FJ, Vasen HF. Hennink SD, et al. Among authors: tops c. Fam Cancer. 2013 Jun;12(2):347-54. doi: 10.1007/s10689-013-9655-6. Fam Cancer. 2013. PMID: 23681793

2

EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancer.

Jagmohan-Changur S, Poikonen T, Vilkki S, Launonen V, Wikman F, Orntoft TF, Møller P, Vasen H, Tops C, Kolodner RD, Mecklin JP, Järvinen H, Bevan S, Houlston RS, Aaltonen LA, Fodde R, Wijnen J, Karhu A. Jagmohan-Changur S, et al. Among authors: tops c. Cancer Res. 2003 Jan 1;63(1):154-8. Cancer Res. 2003. PMID: 12517792

3

Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer.

de Jong AE, van Puijenbroek M, Hendriks Y, Tops C, Wijnen J, Ausems MG, Meijers-Heijboer H, Wagner A, van Os TA, Bröcker-Vriends AH, Vasen HF, Morreau H. de Jong AE, et al. Among authors: tops c. Clin Cancer Res. 2004 Feb 1;10(3):972-80. doi: 10.1158/1078-0432.ccr-0956-3. Clin Cancer Res. 2004. PMID: 14871975

4

Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome).

Hendriks YM, Jagmohan-Changur S, van der Klift HM, Morreau H, van Puijenbroek M, Tops C, van Os T, Wagner A, Ausems MG, Gomez E, Breuning MH, Bröcker-Vriends AH, Vasen HF, Wijnen JT. Hendriks YM, et al. Among authors: tops c. Gastroenterology. 2006 Feb;130(2):312-22. doi: 10.1053/j.gastro.2005.10.052. Gastroenterology. 2006. PMID: 16472587

5

Enrichment of low penetrance susceptibility loci in a Dutch familial colorectal cancer cohort.

Middeldorp A, Jagmohan-Changur S, van Eijk R, Tops C, Devilee P, Vasen HF, Hes FJ, Houlston R, Tomlinson I, Houwing-Duistermaat JJ, Wijnen JT, Morreau H, van Wezel T. Middeldorp A, et al. Among authors: tops c. Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):3062-7. doi: 10.1158/1055-9965.EPI-09-0601. Epub 2009 Oct 20. Cancer Epidemiol Biomarkers Prev. 2009. PMID: 19843678

6

Identification of HNPCC by molecular analysis of colorectal and endometrial tumors.

Vasen HF, Hendriks Y, de Jong AE, van Puijenbroek M, Tops C, Bröcker-Vriends AH, Wijnen JT, Morreau H. Vasen HF, et al. Among authors: tops c. Dis Markers. 2004;20(4-5):207-13. doi: 10.1155/2004/391039. Dis Markers. 2004. PMID: 15528786 Free PMC article. Review.

7

Evaluation of current prediction models for Lynch syndrome: updating the PREMM5 model to identify PMS2 mutation carriers.

Goverde A, Spaander MCW, Nieboer D, van den Ouweland AMW, Dinjens WNM, Dubbink HJ, Tops CJ, Ten Broeke SW, Bruno MJ, Hofstra RMW, Steyerberg EW, Wagner A. Goverde A, et al. Among authors: tops cj. Fam Cancer. 2018 Jul;17(3):361-370. doi: 10.1007/s10689-017-0039-1. Fam Cancer. 2018. PMID: 28933000 Free PMC article.

8

Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors.

Rahner N, Brockschmidt FF, Steinke V, Kahl P, Becker T, Vasen HF, Wijnen JT, Tops CJ, Holinski-Feder E, Ligtenberg MJ, Spruijt L, Görgens H, Stemmler S, Kloor M, Dietmaier W; Dutch Cancer Genetics Group; Schumacher J, Nöthen MM, Propping P. Rahner N, et al. Fam Cancer. 2012 Mar;11(1):19-26. doi: 10.1007/s10689-011-9489-z. Fam Cancer. 2012. PMID: 22086303

9

Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors.

Hendriks Y, Franken P, Dierssen JW, De Leeuw W, Wijnen J, Dreef E, Tops C, Breuning M, Bröcker-Vriends A, Vasen H, Fodde R, Morreau H. Hendriks Y, et al. Among authors: tops c. Am J Pathol. 2003 Feb;162(2):469-77. doi: 10.1016/S0002-9440(10)63841-2. Am J Pathol. 2003. PMID: 12547705 Free PMC article.

10

Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.

Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, Quehenberger F, Sandkuijl L, Møller P, Genuardi M, Van Houwelingen H, Tops C, Van Puijenbroek M, Verkuijlen P, Kenter G, Van Mil A, Meijers-Heijboer H, Tan GB, Breuning MH, Fodde R, Wijnen JT, Bröcker-Vriends AH, Vasen H. Hendriks YM, et al. Among authors: tops c. Gastroenterology. 2004 Jul;127(1):17-25. doi: 10.1053/j.gastro.2004.03.068. Gastroenterology. 2004. PMID: 15236168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters